VaramirStart free · no cardSign in
GRAL as of Oct 31 · 20:30 ET
GRALNasdaqServices-Medical Laboratories

Grail, Inc. · Brief

Next report

3 days

Nov 4 · after closeconfirmedQ3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
5 of 8≥ implied
avg implied
±12.4%
avg realized
±15.9%
Feb 20 '25±13.0%▼−14.72%×1.13
May 13 '25±15.8%▼−23.32%×1.48
Aug 12 '25±13.6%▲+1.13%×0.08
Q3 FY25±12.5%▼−1.85%×0.15
Jan 12 '26±9.5%▲+5.82%×0.61
Feb 19 '26±7.3%▼−50.55%×6.95
Q1 FY26±13.3%▲+15.35%×1.16
Q2 FY26±14.1%▼−14.53%×1.03
quarterimplied−55%0+55%realized×
Q2 FY26±14.1%▼−14.53%×1.03
Q1 FY26±13.3%▲+15.35%×1.16
Feb '26±7.3%▼−50.55%×6.95
Jan '26±9.5%▲+5.82%×0.61
Q3 FY25±12.5%▼−1.85%×0.15
Aug '25±13.6%▲+1.13%×0.08
2 older reports
May '25±15.8%▼−23.32%×1.48
Feb '25±13.0%▼−14.72%×1.13
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 4 report · confirmed

Bull2 of 4

14disclosed supplier and customer ties in SEC filingsSEC filings
4tracked funds holding the companyN-PORT · Aug 31 '26

Bear2

5 of 24largest reporting managers cutting their stake in the latest quarter13F · Jun 30 '26
3 of 8recent reports with moves under the options implied rangeEarnings history
AI captions · Oct 26 '26once per report · top 2 per case

Linked exposure

GRAL report session

Suppliers 2

TWSTTwist Bioscience×0.31ILMNIllumina×0.15
× = co-movement · max 500dSource: SEC filings · market data

Latest changes

30 daysAll changes
Oct 21report dateEarnings date confirmed: Nov 4, after close.Source
Oct 21impliedImplied move: ±17.9% into Nov 4 earnings (Oct 21 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.